GAIPET Trademark

Trademark Overview


On Wednesday, November 8, 2023, a trademark application was filed for GAIPET with the United States Patent and Trademark Office. The USPTO has given the GAIPET trademark a serial number of 79392554. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 10, 2024. This trademark is owned by ARGORNA PHARMACEUTICALS CO., LTD. The GAIPET trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Medicines for human purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; biochemical medicines for the treatment of tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; pharmaceutical preparations for the treatment of tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; chemical reagents for medical and veterinary purposes; biological preparations for medical purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and ins...

Chemical reagents, other than for medical or veterinary purposes; biological preparations for use in industry and science, other than for medical or veterinary purposes; diagnostic preparations for scientific use, other than for medical or veterinary purposes; test paper, chemical; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemicals preparations for scientific use; chemical substances for analyses in laboratories for scientific use, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purpose; biological preparations for cell culture, other than for medical or veterinary use; diagnostic reagents and preparations for scientific use except for medical and veterinary use; active chemical ingredients for use in the manufacture of pharmaceuticals for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular disea...

Scientific development and research services in the field of drugs; vaccine research and development services; scientific research and development of new products for others; scientific research; research of biochemistry; biotechnology research; pharmaceutical drug research; development services in the field of pharmaceutical drugs; medical research service; biomedical research services
gaipet

General Information


Serial Number79392554
Word MarkGAIPET
Filing DateWednesday, November 8, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements


Goods and ServicesMedicines for human purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; biochemical medicines for the treatment of tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; pharmaceutical preparations for the treatment of tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; chemical reagents for medical and veterinary purposes; biological preparations for medical purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; reagent paper for medical purposes; drugs for medical purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; diagnostic preparations for medical purposes; vaccines
Pseudo MarkGAI PET
Goods and ServicesChemical reagents, other than for medical or veterinary purposes; biological preparations for use in industry and science, other than for medical or veterinary purposes; diagnostic preparations for scientific use, other than for medical or veterinary purposes; test paper, chemical; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemicals preparations for scientific use; chemical substances for analyses in laboratories for scientific use, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purpose; biological preparations for cell culture, other than for medical or veterinary use; diagnostic reagents and preparations for scientific use except for medical and veterinary use; active chemical ingredients for use in the manufacture of pharmaceuticals for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia
Goods and ServicesScientific development and research services in the field of drugs; vaccine research and development services; scientific research and development of new products for others; scientific research; research of biochemistry; biotechnology research; pharmaceutical drug research; development services in the field of pharmaceutical drugs; medical research service; biomedical research services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameARGORNA PHARMACEUTICALS CO., LTD
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameARGORNA PHARMACEUTICALS CO., LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Monday, April 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 5, 2024APPLICATION FILING RECEIPT MAILED
Monday, June 17, 2024ASSIGNED TO EXAMINER
Thursday, March 28, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 28, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 24, 2024REFUSAL PROCESSED BY MPU
Sunday, November 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, November 17, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, November 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, August 11, 2024REFUSAL PROCESSED BY IB
Thursday, June 27, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 24, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB